Related Experiment Video
Updated: Oct 3, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Developing a More Tailored Approach to Patient and Public Involvement with Children and Families in Pediatric
J Preston1,2, B Nafria3, A Ohmer4
1Faculty of Health and Life Sciences, Women's and Children's Health, Liverpool Health Partners, University of Liverpool, Liverpool, UK. jennifer.preston@liverpool.ac.uk.
Insights
Meaningfully involving children and families in clinical research is crucial for pediatric health care. The International Children's Advisory Network (iCAN) and European Young Person's Advisory Group Network (eYPAGnet) provide practical solutions for patient-centered pediatric research.
Area of Science:
- Pediatric clinical research
- Patient and family engagement
- Health innovation
Background:
- Meaningful involvement of children and families in clinical research is essential for patient-centered care but not yet routine.
- The pediatric research community must adopt strategies for effective child and family participation.
- Current practices lack systematic approaches to integrate pediatric patient and family perspectives throughout the research lifecycle.
Purpose of the Study:
- To describe how international networks have involved children and families in pediatric clinical research design and delivery.
- To offer practical solutions and case studies for enhancing child and family engagement in pediatric research.
- To identify lessons learned from engaging children and families across various stages of pediatric clinical trials.
Main Methods:
- Utilizing case studies from the International Children's Advisory Network (iCAN) and European Young Person's Advisory Group Network (eYPAGnet).
- Assessing patient engagement quality using the seven criteria of the Patient Engagement Quality Guidance (PEQG) tool.
- Documenting practical solutions and lessons learned from real-world pediatric research initiatives.
Main Results:
- Demonstrated successful involvement of children and families in the design and execution of pediatric clinical research.
- Provided practical examples of patient engagement strategies applicable to drug development programs and other pediatric trials.
- Highlighted the value of structured assessment tools like PEQG for evaluating engagement quality.
Conclusions:
- Systematic engagement of children and families significantly enhances the relevance and success of pediatric clinical research.
- International collaboration through networks like iCAN and eYPAGnet facilitates the implementation of effective engagement strategies.
- Adopting quality guidance frameworks is key to ensuring meaningful and impactful patient and family involvement in pediatric health innovation.
Abstract:
Listening to, and acting on, the voices of children and families during clinical research and innovation is fundamental to ensuring enhanced pediatric health care, medicines development, and technological advances. While this is often discussed as an important step in ensuring patient-centered care, involving children and families across the life cycle of clinical research is not currently routine. The pediatric research community needs to address how to meaningfully involve children and families if they are to succeed in designing clinical research that suits the needs of pediatric patients and their families. This paper describes how an international community working under the umbrella International Children's Advisory Network (iCAN) and European Young Person's Advisory Group Network (eYPAGnet) has involved children and families in the design and delivery of pediatric clinical research. It offers practical solutions through various case studies assessed against seven patient engagement quality criteria within the Patient Engagement Quality Guidance (PEQG) tool, highlighting some of the lessons learnt from involving and engaging with children and families across different stages of clinical research, including pediatric trials for drug development programs.
More Related Videos
Related Concept Videos
Patient-centered Care
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Clinical Trials: Overview
Ethical Dilemmas II
Clinical Trials
There are four phases in a clinical trial. A phase one...
Nursing Process for Patient and Caregiver Teaching II: Planning and Implementation

